Alastair Riddell
Chief Operating Officer at SMALL PHARMA INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Sapirstein | M | 63 | 5 years | |
| George Tziras | M | 43 | 3 years | |
| Marie Layzell | F | 46 | 3 years | |
| Rory James Swanton Shaw | M | 70 | 5 years | |
| Lyne Fortin | F | 64 | 3 years | |
| Frank Massam | M | - |
Nemesis Biosciences Ltd.
 Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | 10 years |
| Amy Chandler | F | 56 | - | |
| Dan Lyus | M | - |
South West Peninsula AHSN Ltd.
 South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | 5 years |
| Richard Watson | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Thomas James Oakley | M | 36 | 5 years | |
| Mary Coelho | F | 62 | 3 years | |
| Ed Borkowski | M | 64 | 9 years | |
| Gi Mikawa | M | - |
Nemesis Biosciences Ltd.
Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | 10 years |
| Cristianne Rijcken | M | - |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | 13 years |
| Charles Casamento | M | 78 | 7 years | |
| Conrad Lichtenstein | M | - |
Nemesis Biosciences Ltd.
Nemesis Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Nemesis Biosciences Ltd. develops and commercializes therapeutic agents that resurrect the antibiotic sensitivity of currently resistant microbial pathogens. Its symbiotics kill pathogenic microorganisms directly and/or make them susceptible to currently existing antibiotics. The company was founded by Frank Massam, Conrad Lichtenstein and Gi Mikawa in March 2014 and is headquartered in Cambridge, the United Kingdom. | 10 years |
| Michael Wolfe | M | 58 | 3 years | |
| Axel Mescheder | M | - |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | 6 years |
| Paul Maier | M | 76 | 3 years | |
| Sarah Hamilton | F | - | 2 years | |
| Tatiana Lobanov Rostovsky | F | - | 3 years | |
| Nina Kumari | M | - | 5 years | |
| Ellen James | M | - | 7 years | |
| Jenny Maguire | F | - | 3 years | |
| Rob Liskamp | M | - |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | - |
| Werner Cautreels | M | 71 |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | 5 years |
| Richard Smith | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Gavin Brake | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Stuart Logan | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Sonja Manton | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| John Keith Acornley | M | 71 |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | 5 years |
| Kate Lock | F | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Phillip Confue | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Carol Routledge | M | - | 4 years | |
| Richard Kimel | M | 57 | - | |
| Neil Stevens | M | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Joanna Bayley | F | - |
South West Peninsula AHSN Ltd.
South West Peninsula AHSN Ltd. Medical/Nursing ServicesHealth Services South West Peninsula AHSN Ltd. is a British company that is part of the AHSN Network, which aims to transform the prevention of cardiovascular disease through a national blood pressure optimization program. The private company is based in Exeter, UK. The company's purpose is to transform lives through health and care innovation. The CEO of the company is Richard Watson. | - |
| Mark R.L. Krul | M | - |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | - |
| Marcel Kloosterman | M | - |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | - |
| Janwillem Naesens | M | 41 |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | - |
| Sarah Romano | F | 44 | 2 years | |
| Martin Krusin | M | - | 10 years | |
| Sangeeta Bhatia | M | 55 |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | - |
| David Steel | M | - | 3 years | |
| Govert J. Schouten | M | - |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | - |
| Emma Hodge | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Johan Spoor | M | 52 | 6 years | |
| Peter Rands | M | 43 | 5 years | |
| Maged Shenouda | M | 59 | 4 years | |
| Joanne Holland | M | 49 | 13 years | |
| Lindsay Melvin | M | - | 3 years | |
| Stephen Parker | M | 65 | 6 years | |
| Jia Huey Cheng | F | 48 | 1 years | |
| Gregory Oakes | M | 56 | 2 years | |
| Lars Guldbæk Karlsson | M | 63 | 1 years | |
| Timothy Irish | M | 59 | 5 years | |
| Simon Sturge | M | 65 | 4 years | |
| David James Crabb | M | 57 | - | |
| Sue Furber | F | - |
Stem Cell Sciences Plc
| - |
| Vern Schramm | M | 82 | 4 years | |
| Karl Keegan | M | 57 | 1 years | |
| Jim Sutcliffe | M | - |
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | - |
| Mark Carlton | M | - |
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | 8 years |
| Joost J. M. Holthuis | M | 71 |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | 7 years |
| Jeremy Randall | M | 60 | 5 years | |
| Thomas Charlton | M | 66 | 14 years | |
| Lucio Iannone | M | 41 | 3 years | |
| Monica Gangal | F | - | 2 years | |
| Philippe Jais | M | - | 5 years | |
| David Hoffman | M | 63 | 1 years | |
| Tony Baca | M | - | - | |
| Ted Stover | M | - | - | |
| Alexander Henry Menys | M | 38 | 3 years | |
| Balaji Ganeshan | M | 42 | 3 years | |
| Loreal McDonald | F | - | 1 years | |
| Steven Neilson | M | - | - | |
| Michael Peter Hayball | M | 57 | 3 years | |
| David Dodd | M | 74 |
Stem Cell Sciences Plc
| 3 years |
| Daniel Schneiderman | M | 46 | 2 years | |
| Klaus Giese | M | - | 14 years | |
| Trevor Brown | M | 78 | 3 years | |
| Edwin Moses | M | 69 |
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | 3 years |
| Jeremy Paul Scudamore | M | 76 |
Stem Cell Sciences Plc
| - |
| Daniel Dupret | M | 67 | 5 years | |
| Barry Kenny | M | - |
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | 4 years |
| Alan Munro | M | - |
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | - |
| Annie Cheng | F | - | - | |
| Oliver von Stein | M | - | 1 years | |
| Hugh Alexander Ilyine | M | 72 |
Stem Cell Sciences Plc
| - |
| Michael Dexter | M | - |
Stem Cell Sciences Plc
| 6 years |
| Peter Mountford | M | - |
Stem Cell Sciences Plc
| - |
| Samuel Aparicio | M | - |
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | 8 years |
| James William Buckie | M | 63 |
Pharmagene Plc
| 4 years |
| James Pennington | M | 81 | 4 years | |
| Marcelo Piccirillo | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 48 | 50.53% |
| United States | 22 | 23.16% |
| Canada | 15 | 15.79% |
| Netherlands | 10 | 10.53% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alastair Riddell
- Personal Network
